Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(66.7%)

Phase 4

1(33.3%)

3Total

N/A(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06693622Recruiting

Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests

Role: collaborator

NCT03770351Unknown

Early Prostate Cancer: Predicting Treatment Response

Role: collaborator

NCT00498550Phase 4Completed

Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual

Role: collaborator

NCT02145117Not ApplicableUnknown

Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)

Role: collaborator

NCT02436057Not ApplicableCompleted

Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform

Role: collaborator

All 5 trials loaded